These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31313753)

  • 21. Thyroid eye disease: a review.
    Weiler DL
    Clin Exp Optom; 2017 Jan; 100(1):20-25. PubMed ID: 27701774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current trends in the management of thyroid eye disease.
    Rao R; MacIntosh PW; Yoon MK; Lefebvre DR
    Curr Opin Ophthalmol; 2015 Nov; 26(6):484-90. PubMed ID: 26397888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pediatric Thyroid Eye Disease: Clinical Characteristics and Orbital Decompression Outcomes.
    Chua MR; Tomlinson LA; Binenbaum G; Katowitz WR
    Ophthalmic Plast Reconstr Surg; 2018; 34(4S Suppl 1):S52-S55. PubMed ID: 29985836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Chinese survey of clinical practice on the management of thyroid eye disease.
    Chen J; Li C; Teng W; Shan Z; Jin J; Wei Y; Sun J; Li Y; Zhou H
    Eur Thyroid J; 2024 Jun; 13(3):. PubMed ID: 38642583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological treatments for thyroid eye disease.
    Modjtahedi SP; Modjtahedi BS; Mansury AM; Selva D; Douglas RS; Goldberg RA; Leibovitch I
    Drugs; 2006; 66(13):1685-700. PubMed ID: 16978034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coincidental Optic Nerve Meningioma and Thyroid Eye Disease.
    Garg A; Patel P; Lignelli A; Baron E; Kazim M
    Ophthalmic Plast Reconstr Surg; 2015; 31(4):e94-5. PubMed ID: 24833445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal management of Graves orbitopathy: a multidisciplinary approach.
    Soeters MR; van Zeijl CJ; Boelen A; Kloos R; Saeed P; Vriesendorp TM; Mourits MP
    Neth J Med; 2011; 69(7):302-8. PubMed ID: 21934174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyroid eye disease: Redefining its management-A review.
    Jain AP; Jaru-Ampornpan P; Douglas RS
    Clin Exp Ophthalmol; 2021 Mar; 49(2):203-211. PubMed ID: 33484076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging therapies in the medical management of thyroid eye disease.
    Kamboj A; Harrison AR; Mokhtarzadeh A
    Front Ophthalmol (Lausanne); 2023; 3():1295902. PubMed ID: 38983101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical orbital decompression for thyroid eye disease.
    Boboridis KG; Bunce C
    Cochrane Database Syst Rev; 2011 Dec; (12):CD007630. PubMed ID: 22161415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Update on endocrine orbitopathy].
    Ponto KA; Kahaly GJ; Pitz S
    Klin Monbl Augenheilkd; 2009 Feb; 226(2):R13-28; quiz R29-31. PubMed ID: 19206039
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment modalities of thyroid related orbitopathy.
    Ahn ES; Subramanian PS
    Indian J Ophthalmol; 2014 Oct; 62(10):999-1002. PubMed ID: 25449934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunotherapies for thyroid eye disease.
    Kahaly GJ
    Curr Opin Endocrinol Diabetes Obes; 2019 Oct; 26(5):250-255. PubMed ID: 31356255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Graves' ophthalmopathy].
    Eckstein A; Dekowski D; Führer-Sakel D; Berchner-Pfannschmidt U; Esser J
    Ophthalmologe; 2016 Apr; 113(4):349-64; quiz 465-6. PubMed ID: 27059986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcomes of orbital fat decompression in Graves' orbitopathy.
    Cheng AM; Wei YH; Tighe S; Sheha H; Liao SL
    Br J Ophthalmol; 2018 Jan; 102(1):69-73. PubMed ID: 28450378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pathogenesis of thyroid eye disease - does autoimmunity against the TSH receptor explain all cases?].
    Wall JR; Lahooti H
    Endokrynol Pol; 2011; 62 Suppl 1():1-7. PubMed ID: 22125104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging Investigation of Thyroid Eye Disease.
    Siakallis LC; Uddin JM; Miszkiel KA
    Ophthalmic Plast Reconstr Surg; 2018; 34(4S Suppl 1):S41-S51. PubMed ID: 29905640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenesis of thyroid eye disease--does autoimmunity against the TSH receptor explain all cases?
    Wall JR; Lahooti H
    Endokrynol Pol; 2010; 61(2):222-7. PubMed ID: 20464711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation and management of Graves' orbitopathy.
    Lee HB; Rodgers IR; Woog JJ
    Otolaryngol Clin North Am; 2006 Oct; 39(5):923-42, vi. PubMed ID: 16982255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality of life in thyroid eye disease: impact of quality of care.
    Estcourt S; Quinn AG; Vaidya B
    Eur J Endocrinol; 2011 May; 164(5):649-55. PubMed ID: 21367964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.